Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial

Autor: Mensink, Frans B., Los, Jonathan, Oemrawsingh, Rohit M., von Birgelen, Clemens, Ijsselmuiden, Alexander, Meuwissen, Martijn, Cheng, Jin M., van Wijk, Diederik F., Smits, Pieter C., Paradies, Valeria, van der Heijden, Dirk J., Rai, Himanshu, ten Cate, Tim JF., Camaro, Cyril, Damman, Peter, van Nunen, Lokien X., Dimitriu-Leen, Aukelien C., van Wely, Marleen H., Cetinyurek-Yavuz, Aysun, Byrne, Robert A., van Royen, Niels, van Geuns, Robert-Jan M.
Zdroj: In Heliyon 15 October 2024 10(19)
Databáze: ScienceDirect